- ￥1338 - 9188
- abinScience
- China
- VK685123
- 2026年04月02日
- Human
- Hendra virus, Nipah virus
企业认证
相关产品推荐更多 >
Anti-Human PODXL Antibody (Mab60), PerCP, 抗人PODXL抗体 (Mab60), PerCP标记
询价
Anti-Human SEMA4A Antibody (SAA1904), 抗人SEMA4A抗体 (SAA1904)
￥1176Anti-DPYD Polyclonal Antibody, 抗DPYD多克隆抗体
￥1008Anti-Human CD326/EPCAM Antibody (MT201), FITC, 抗人CD326/EPCAM抗体 (MT201), FITC标记
询价
Anti-phospho-Histone H2A.X (Ser139) Antibody (C6), 抗phospho-HistoneH2A.X (Ser139)抗体 (C6)
￥1338
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 克隆性：
Monoclonal
- 标记物：
Unconjugated
- 适应物种：
Hendra virus, Nipah virus
- 保质期：
1 year
- 抗原来源：
Human
- 目录编号：
VK685123
- 级别：
科研级别
- 库存：
999
- 供应商：
abinScience
- 宿主：
Human
- 靶点：
G, Glycoprotein G
- 规格：
50ug/100ug/1mg
| 规格： | 50ug | 产品价格： | ￥1338.0 |
|---|---|---|---|
| 规格： | 100ug | 产品价格： | ￥2288.0 |
| 规格： | 1mg | 产品价格： | ￥9188.0 |
| Product name | Anti-HeV/NiV Glycoprotein G Antibody (41-6) |
|---|---|
| Catalog No. | VK685123 |
| Host species | Human |
| Species reactivity | Hendra virus, Nipah virus |
| Immunogen | \ |
| Form | Liquid |
| Storage buffer | 0.01M PBS pH 7.4 |
| Clonality | Monoclonal |
| Isotype | IgG1, kappa |
| Applications | ELISA, Neutralization |
| Target | G, Glycoprotein G |
| Purification | Protein A/G purified from cell culture supernatant. |
| Endotoxin level | Please contact with the lab for this information. |
| Accession | Q9IH62, O89343 |
| Stability and Storage | Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt. |
| Clone ID | 41-6 |
| Note | For research use only. |
abinScience, founded in 2023 in Strasbourg, France, is committed to developing and producing high-quality life science reagents. Rooted in one of Europe’s leading hubs for scientific innovation, abinScience empowers global research through reliable, efficient experimental solutions. Guided by the vision of “Empowering Bioscience Discovery,” we support scientists worldwide in advancing the frontiers of bioscience.
Technology and Innovation
Relying on the global leading position in antibody and protein research and more than 20 years of industry experience of its parent company ProteoGenix since 2003, abinScience has inherited advanced technologies and high-quality standards. In particular, the XtenCHO™ system developed by ProteoGenix, which has two modes of transient expression and stable expression, has been widely recognized as a core technology to improve the efficiency of protein production, providing a solid foundation for abinScience's product quality.
Product categories and application fields.
Main products.
10000+ high-activity proteins.
15000+ antibody series products:
Classic monoclonal antibody.
Monoclonal antibody
Internal control antibody, labeled antibody.
High-quality phosphorylation antibodies.
Highly specific nanobodies and small molecule antibodies.
Functional antibodies in vivo.
Low-background flow cytometry antibodies.
DNA/RNA antibodies and PEG antibodies.
1000+ reagent kit series products.
Large-scale packaging customization services: We offer personalized antibody design, protein production, molecular optimization, and experimental development services.
Application field
Infectious disease research: including viruses, superbugs, parasites, etc.
Neuroscience research: Supporting research on neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s disease.
Immunology research: Covers the research needs of immune activation, inhibition, and allergies and abnormal reactions.
Oncology research: Supporting the development of tumor biology and anti-tumor drugs.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验Expression, Purification, and Characterization of Engineered Antibody CH2 and VH Domains
or absent binding to regions on the surface of some molecules (e.g., on the HIV envelope glycoprotein) which are fully accessible only by molecules of smaller size. Therefore, much work especially during the last decade has been aimed at developing novel
.Anticyclophilin autoantibodies were found in 48% of the SLE patients. The positive rate of IgG, IgA and IgM anti-cyclophilin A antibody is 36%, 20% and 18%, respectively. The prevelance of antibodies to CyPA in patients with skin and mucous lesion, leukopenia
”： Small bivalent antibody fragment. Cancer ImmunolImmunother， 1997， 45：128-130.[4] Zhu Z P， Zapata G， Shalaby R， et al. High level secretion of a humanized bispecific diabody from Escherichia coli. Bio/technology，1996，14：192-196.[5] Shen D C（沈德诚），Yang X F
技术资料暂无技术资料 索取技术资料
